188 related articles for article (PubMed ID: 21936874)
21. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
[TBL] [Abstract][Full Text] [Related]
22. Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.
Al-Shareef H; Hiraoka SI; Tanaka N; Shogen Y; Lee AD; Bakhshishayan S; Kogo M
Oncol Rep; 2016 Nov; 36(5):2444-2454. PubMed ID: 27666723
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
[TBL] [Abstract][Full Text] [Related]
24. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral Cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract][Full Text] [Related]
25. Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.
Ishii H; Chikamatsu K; Sakakura K; Miyata M; Furuya N; Masuyama K
Oral Oncol; 2010 May; 46(5):373-8. PubMed ID: 20308006
[TBL] [Abstract][Full Text] [Related]
26. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
27. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
28. [Expression of VEGF-C and its correlation with cervical lymph nodes metastasis of oral cancers].
Wen Y; Yu D; Wang C; Li L; Wang X; Tang X; Fu F
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Feb; 19(1):5-8. PubMed ID: 12539624
[TBL] [Abstract][Full Text] [Related]
29. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
Front Immunol; 2018; 9():412. PubMed ID: 29599774
[TBL] [Abstract][Full Text] [Related]
30. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
31. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor.
Tang Y; Zhang D; Fallavollita L; Brodt P
Cancer Res; 2003 Mar; 63(6):1166-71. PubMed ID: 12649170
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
34. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma.
Lopes MA; Nikitakis NG; Reynolds MA; Ord RA; Sauk J
J Oral Maxillofac Surg; 2002 Feb; 60(2):142-7; discussion 147-8. PubMed ID: 11815908
[TBL] [Abstract][Full Text] [Related]
37. The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25.
Duarte A; Silveira GG; Soave DF; Costa JPO; Silva AR
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3377-3383. PubMed ID: 31759362
[TBL] [Abstract][Full Text] [Related]
38. Microvesicles releasing by oral cancer cells enhance endothelial cell angiogenesis via Shh/RhoA signaling pathway.
Huaitong X; Yuanyong F; Yueqin T; Peng Z; Wei S; Kai S
Cancer Biol Ther; 2017 Oct; 18(10):783-791. PubMed ID: 28886265
[TBL] [Abstract][Full Text] [Related]
39. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
